日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Japan's Perspective on Facilitating Drug Development Through Asian Cooperation in Multi-Regional Clinical Trials: Insights From Regulatory Research

日本对通过亚洲多区域临床试验合作促进药物研发的看法:来自监管研究的启示

Tohkin, Masahiro; Saito, Yoshiro; Uyama, Yoshiaki

Prediction of Cisplatin-Induced Acute Kidney Injury Using an Interpretable Machine Learning Model and Electronic Medical Record Information

利用可解释的机器学习模型和电子病历信息预测顺铂引起的急性肾损伤

Ambe, Kaori; Aoki, Yuka; Murashima, Miho; Wachino, Chiharu; Deki, Yuto; Ieda, Masaya; Kondo, Masahiro; Furukawa-Hibi, Yoko; Kimura, Kazunori; Hamano, Takayuki; Tohkin, Masahiro

Comparison of the Efficacy and Safety of Disease-Modifying Antirheumatic Drugs Combination Therapies: A Systematic Review and Network Meta-Analysis

比较改善病情抗风湿药物联合疗法的疗效和安全性:系统评价和网络荟萃分析

Liu, Linfeng; Ambe, Kaori; Onishi, Mayu; Yoshii, Yuka; Makino, Toshiaki; Tohkin, Masahiro

Machine Learning-Based In Silico Prediction of the Inhibitory Activity of Chemical Substances Against Rat and Human Cytochrome P450s

基于机器学习的化学物质对大鼠和人细胞色素P450抑制活性的计算机模拟预测

Ambe, Kaori; Nakamori, Mizuki; Tohno, Riku; Suzuki, Kotaro; Sasaki, Takamitsu; Tohkin, Masahiro; Yoshinari, Kouichi

Epidemiology and predictors of hyponatremia in a contemporary cohort of patients with malignancy: a retrospective cohort study

当代恶性肿瘤患者低钠血症的流行病学及预测因素:一项回顾性队列研究

Murashima, Miho; Ambe, Kaori; Aoki, Yuka; Kasugai, Takahisa; Tomonari, Tatsuya; Ono, Minamo; Mizuno, Masashi; Tohkin, Masahiro; Hamano, Takayuki

Influence of anticancer agents on sexual function: An in vivo study based on the US FDA Adverse Event Reporting System

抗癌药物对性功能的影响:一项基于美国FDA不良事件报告系统的体内研究

Kataoka, Tomoya; Sanagawa, Akimasa; Suzuki, Jun; Muto, Tatsuya; Hotta, Yuji; Kawade, Yoshihiro; Maeda, Yasuhiro; Tohkin, Masahiro; Kimura, Kazunori

Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan

实施ICH E17指南需要考虑的要点:从日本以往的多区域临床试验中汲取经验

Asano, Kunihito; Aoi, Yoko; Kamada, Shuji; Uyama, Yoshiaki; Tohkin, Masahiro

HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1)

接受硼替佐米治疗的日本多发性骨髓瘤患者的HLA基因分型:JCOG1105(JCOG1105A1)探索性生物标志物研究

Ri, Masaki; Iida, Shinsuke; Maruyama, Dai; Sakabe, Aya; Kamei, Ryo; Nakashima, Takuto; Tohkin, Masahiro; Osaga, Satoshi; Tobinai, Kensei; Fukuhara, Noriko; Miyazaki, Kana; Tsukamoto, Norifumi; Tsujimura, Hideki; Yoshimitsu, Makoto; Miyamoto, Kenichi; Tsukasaki, Kunihiro; Nagai, Hirokazu

Real-world evidence of population differences in allopurinol-related severe cutaneous adverse reactions in East Asians: A population-based cohort study

东亚人群中别嘌醇相关严重皮肤不良反应的群体差异的真实世界证据:一项基于人群的队列研究

Sato, Tsugumichi; Cheng, Ching-Lan; Park, Heung-Woo; Kao Yang, Yea-Huei; Yang, Min-Suk; Fujita, Mizuki; Kumagai, Yuji; Tohkin, Masahiro; Saito, Yoshiro; Sai, Kimie

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database

利用日本药物不良事件报告数据库,通过计算机模拟方法预测严重皮肤不良反应

Ambe, Kaori; Ohya, Kazuyuki; Takada, Waki; Suzuki, Masaharu; Tohkin, Masahiro